We are pleased to announce that Novo Nordisk will serve as a Bronze Sponsor for the 2024 Frontiers Health conference.

Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Novo Nordisk’s purpose is to drive change to defeat serious chronic diseases, built upon the company’s heritage in diabetes. This is achieved by pioneering scientific breakthroughs, expanding access to medicines and working to prevent and ultimately cure disease.

The Transformational Prevention Unit (TPU) is a pioneering scientific and business innovation unit within Novo Nordisk whose mission is to increase obesity-free life years. By leveraging Novo Nordisk’s deep knowledge of the science of obesity, the TPU aims to deliver scientifically anchored, empowering, and scalable commercial solutions that predict and pre-empt obesity and its consequences through innovative partnerships.

Join the conference in Berlin on October 17 to hear the keynote address by TPU Founder and Head, Nadeem Sarwar, and attend the panel discussion with TPU Product Creator, Jutta Skau.